ClinConnect ClinConnect Logo
Search / Trial NCT05081284

Clinical Outcomes of Immediate Implants With or Without a Volume-stable Collagen Matrix

Launched by UNIVERSITY OF PISA · Oct 4, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Soft Tissue Augmentation Immediate Implant Collagen Matrix

ClinConnect Summary

This clinical trial is looking at how well patients heal after getting dental implants right after having a tooth removed. Specifically, it will compare outcomes between patients who receive a special collagen matrix to help support the healing process and those who do not. The goal is to see if this added support makes a difference in the health of the surrounding soft tissue around the implant.

To be eligible for this study, participants need to have a single tooth that is failing and located in the front part of the mouth, with healthy neighboring teeth. However, certain individuals will not qualify, including those who smoke heavily, have specific health conditions that could slow healing, or have severe gum disease. Participants can expect to be part of a study that aims to improve dental implant procedures, with careful monitoring of their healing progress. This trial is currently recruiting participants aged 65 to 74, and it is open to everyone regardless of gender.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Presence of a single failing tooth in the esthetic region (second premolar to contralateral second premolar), the adjacent teeth should be present and without any dental pathologies.
  • Exclusion Criteria:
  • Patients who are heavy smokers (more than 10 cigarettes/day);
  • Patients who suffer from any systemic diseases that could negatively influence wound healing;
  • Patients who received head and neck radiation treatment;
  • Patients who have a full contraindication to implant surgery;
  • Patients who have uncontrolled periodontal disease;
  • Patients who show a full mouth plaque and bleeding score higher than 25%;
  • Patients who have deficient extraction sockets according to the classification of Juodzbalys et al. 2008.
  • Patients with known allergy, sensitivity or intolerance to collagen
  • Patients who are pregnant or who are breastfeeding

About University Of Pisa

The University of Pisa is a prestigious academic institution renowned for its commitment to advancing scientific research and education. With a rich history dating back to the 12th century, the university is dedicated to fostering innovation and excellence in various fields, including medicine and health sciences. As a clinical trial sponsor, the University of Pisa leverages its robust research infrastructure and interdisciplinary expertise to conduct rigorous clinical studies aimed at improving patient outcomes and contributing to the body of medical knowledge. Its collaborative approach involves partnerships with healthcare institutions and industry stakeholders, ensuring that research is aligned with the highest ethical standards and regulatory compliance.

Locations

Pisa, , Italy

Patients applied

HB

1 patients applied

Trial Officials

Antonio Barone, DDS

Principal Investigator

University of Pisa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials